Cefurim CV 500 mg+125 mg (Tablet)

Unit Price: ৳ 55.00 (2 x 4: ৳ 440.00)

Strip Price: ৳ 220.00

Medicine Details

Category	Details
Generic	Cefuroxime axetil clavulanic acid
Company	Somatec pharmaceuticals ltd
Also available as	Cefurim cv 125 mg suspension Cefurim cv 250 mg tablet

Cefurim CV 500 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria.
Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains.
Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process.
Clavulanic acid is a naturally derived beta-lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta-lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them.
Cefuroxime-Clavulanic Acid tablet may be taken without regard to food.

250 mg b.i.d. for 5-10 days for pharyngitis/tonsillitis
250 mg b.i.d. for 10 days for acute bacterial maxillary sinusitis
250-500 mg b.i.d. for 10 days for acute bacterial exacerbation of chronic bronchitis
250-500 mg b.i.d. for 5-10 days for secondary bacterial infections of acute bronchitis
250-500 mg b.i.d. for 10 days for uncomplicated skin and skin structure infections
250 mg b.i.d. for 7-10 days for uncomplicated urinary tract infections
1000 mg b.i.d. Single dose for uncomplicated gonorrhoea
250-500 mg b.i.d. for 5-10 days for community-acquired pneumonia
500 mg b.i.d. for 10-14 days for MDR typhoid fever
500 mg b.i.d. for 20 days for early Lyme disease
20 mg/kg/day b.i.d for 5-10 days for Pharyngitis/Tonsillitis in pediatric patients
30 mg/kg/day b.i.d for 10 days for Acute otitis media in pediatric patients
30 mg/kg/day b.i.d for 10 days for Acute bacterial maxillary sinusitis in pediatric patients
30 mg/kg/day b.i.d for 10 days for Impetigo in pediatric patients

Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%.
Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime.

Nausea
Vomiting
Diarrhea
Abdominal discomfort or pain
Prolonged administration may result in overgrowth of nonsusceptible microorganisms
Renal dysfunction (rare)
Anaphylaxis (rare)
Angioedema (rare)
Pruritus (rare)
Rash (rare)

Given with care to patients receiving concurrent treatment with potent diuretics
Given with care to patients with a history of colitis